Clinical Trials Browser

Phase 2 × pexidartinib × 90 days × Clear all

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

Clinical Trials